Costly IVF add-ons fail to show benefits, new study finds

A recent study in The Lancet reveals that many expensive add-ons to IVF treatments, touted by clinics to boost success rates, don't actually deliver on their promises. This means patients could be spending thousands of dollars on unproven procedures without significant benefits. The findings are crucial because they highlight the need for more transparent and evidence-based practices in fertility treatments, potentially saving money and emotional stress for those seeking to conceive. This study underscores the importance of relying on scientifically validated methods rather than marketing hype.